PT3305770T - Processo para a produção de forma cristalina de enzalutamida - Google Patents

Processo para a produção de forma cristalina de enzalutamida

Info

Publication number
PT3305770T
PT3305770T PT168032480T PT16803248T PT3305770T PT 3305770 T PT3305770 T PT 3305770T PT 168032480 T PT168032480 T PT 168032480T PT 16803248 T PT16803248 T PT 16803248T PT 3305770 T PT3305770 T PT 3305770T
Authority
PT
Portugal
Prior art keywords
producing
crystal form
enzalutamide
enzalutamide crystal
producing enzalutamide
Prior art date
Application number
PT168032480T
Other languages
English (en)
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PT3305770T publication Critical patent/PT3305770T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/28Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B33/00After-treatment of single crystals or homogeneous polycrystalline material with defined structure
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Glass Compositions (AREA)
PT168032480T 2015-05-29 2016-05-27 Processo para a produção de forma cristalina de enzalutamida PT3305770T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015109805 2015-05-29

Publications (1)

Publication Number Publication Date
PT3305770T true PT3305770T (pt) 2023-04-26

Family

ID=57442345

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168032480T PT3305770T (pt) 2015-05-29 2016-05-27 Processo para a produção de forma cristalina de enzalutamida

Country Status (11)

Country Link
US (1) US10118899B2 (pt)
EP (1) EP3305770B1 (pt)
JP (1) JP6753396B2 (pt)
CN (1) CN107635969B (pt)
CA (1) CA2987563C (pt)
ES (1) ES2942618T3 (pt)
HK (1) HK1251218A1 (pt)
MX (1) MX2017014958A (pt)
PL (1) PL3305770T3 (pt)
PT (1) PT3305770T (pt)
WO (1) WO2016194813A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3990435A1 (en) * 2019-06-27 2022-05-04 Synthon B.V. Process for preparation of enzalutamide
CA3152909A1 (en) 2019-10-03 2021-04-08 Synthon Bv Pharmaceutical composition comprising enzalutamide
CN111217757B (zh) * 2020-01-06 2021-03-19 武汉大学 一种恩杂鲁胺化合物及其药物组合物制剂
CN111303042A (zh) * 2020-03-25 2020-06-19 北京赛思源生物医药技术有限公司 一种恩杂鲁胺的新晶型
CN114591246A (zh) * 2022-03-25 2022-06-07 重庆华邦制药有限公司 一种恩扎卢胺的纯化方法
CN115536591A (zh) * 2022-09-27 2022-12-30 爱斯特(成都)生物制药股份有限公司 一种连续流制备恩扎卢胺的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52274B2 (sr) * 2005-05-13 2018-05-31 Univ California Jedinjenje diarilhidantoina
HUE055051T2 (hu) * 2010-02-24 2021-10-28 Medivation Prostate Therapeutics Llc Eljárás diaril-tiohidantoin és diaril-hidantoin vegyületek szintézisére
WO2011157657A1 (en) * 2010-06-14 2011-12-22 Solvay Solexis S.P.A. Pvdf coating compositions
RU2015113434A (ru) 2012-09-11 2016-11-10 Др. Редди'С Лабораторис Лимитед Полиморфные формы энзалутамида и их получение
CN106543085A (zh) 2013-10-14 2017-03-29 杭州普晒医药科技有限公司 恩杂鲁胺的固态形式及其制备方法和用途
US9611225B2 (en) 2014-01-27 2017-04-04 Cadila Healthcare Limited Process for preparation of androgen receptor antagonist
WO2016005875A1 (en) 2014-07-11 2016-01-14 Shilpa Medicare Limited An improved process for the preparation of enzalutamide
CN104610158A (zh) 2015-02-03 2015-05-13 江苏慧博生物科技有限公司 一种恩杂鲁胺的精制方法
ITUB20151204A1 (it) * 2015-05-28 2016-11-28 Olon Spa Procedimento per la preparazione di enzalutamide

Also Published As

Publication number Publication date
EP3305770A4 (en) 2018-12-12
US20180148417A1 (en) 2018-05-31
CA2987563C (en) 2024-04-09
HK1251218A1 (zh) 2019-01-25
ES2942618T3 (es) 2023-06-05
EP3305770B1 (en) 2023-03-29
JPWO2016194813A1 (ja) 2018-06-07
EP3305770A1 (en) 2018-04-11
WO2016194813A1 (ja) 2016-12-08
CN107635969A (zh) 2018-01-26
CN107635969B (zh) 2021-08-17
US10118899B2 (en) 2018-11-06
KR20180014015A (ko) 2018-02-07
JP6753396B2 (ja) 2020-09-09
PL3305770T3 (pl) 2023-06-26
MX2017014958A (es) 2018-07-06
CA2987563A1 (en) 2016-12-08

Similar Documents

Publication Publication Date Title
ZA201706213B (en) Process for producing stabilized polyacrylamides
ZA201708142B (en) Process for preparing 4-amino-pyridazines
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
IL289910B1 (en) A method for preparing allulose crystals
SG11201701945RA (en) Process for making cyclohexanone
SG11201700443WA (en) Process for making cyclohexanone
SG11201701429SA (en) Process for making cyclohexanone
PL3227023T3 (pl) Sposób wytwarzania kropel
HK1251218A1 (zh) 製造恩雜魯胺晶形的程序
HK1245278A1 (zh) 製備索非布韋晶型6的方法
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
IL253877B (en) Process for the preparation of 3-chloro-2-vinylphenylsulfonates
SG11201701326YA (en) Method for producing oligosilane
HK1249098A1 (zh) 用於生產氟美他酚的方法
ZA201801650B (en) Process for producing novel 4-benzoazonine derivatives
PT3182981T (pt) Processo de produção de isomaltooligosacarídeos
IL255093A0 (en) A method for the production of levoglucosenon
LT3356541T (lt) L-metionino gamybos būdas
PL3299394T3 (pl) Sposób wytwarzania zmodyfikowanych ksylopolisacharydów
LT3356540T (lt) L-metionino gamybos būdas
SG11201701480VA (en) Process for producing silicon single crystal
KZ31594B (ru) Способ производствашоколада
HUE052742T2 (hu) Eljárás alkaltrészek gyártására
PL3006400T3 (pl) Sposób wytwarzania amoniaku
ZA201803631B (en) Improved process for making crotonylaminopyridines